DSpace About DSpace Software 日本語
 

GINMU >

Browsing by Author 4/0000318

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:   
Sort by: In order: Results/Page Authors/Record:
Showing results 1 to 20 of 22
 next >
Issue DateTitleAuthor(s)
7-May-2015A novel quantitative hemolytic assay coupled with restriction fragment length polymorphisms analysis enabled early diagnosis of atypical hemolytic uremic syndrome and identified unique predisposing mutations in Japan.Yoshida, Yoko; Miyata, Toshiyuki; Matsumoto, Masanori; Shirotani-Ikejima, Hiroko; Uchida, Yumiko; Ohyama, Yoshifumi; Kokubo, Tetsuro; Fujimura, Yoshihiro
May-2012ADAMTS13 activity may predict the cumulative survival of patients with liver cirrhosis in comparison with the Child-Turcotte-Pugh score and the Model for End-Stage Liver Disease score.Takaya, Hiroaki; Uemura, Masahito; Fujimura, Yoshihiro; Matsumoto, Masanori; Matsuyama, Tomomi; Kato, Seiji; Morioka, Chie; Ishizashi, Hiromichi; Hori, Yuji; Fujimoto, Masao; Tsujimoto, Tatsuhiro; Kawaratani, Hideto; Toyohara, Masahisa; Kurumatani, Norio; Fukui, Hiroshi
Dec-2013ADAMTS13 unbound to larger von Willebrand factor multimers in cryosupernatant: Implications for selection of plasma preparations for TTP treatmentHori, Yuji; Hayakawa, Masaki; Isonishi, Ayami; Soejima, Kenji; Matsumoto, Masanori; Fujimura, Yoshihiro
28-Feb-2006ADAMTS13解析によるTTP/HUS診断松本, 雅則; 石指, 宏通; 八木, 秀男; 藤村, 吉博
Jun-2019Blood group antigen A on von Willebrand factor is more protective against ADAMTS13 cleavage than antigens B and H.Hayakawa, Masaki; Kato, Seiji; Matsui, Taei; Sakai, Kazuya; Fujimura, Yoshihiro; Matsumoto, Masanori
Aug-2017Implementation of a rapid assay of ADAMTS13 activity was associated with improved 30-day survival rate in patients with acquired primary thrombotic thrombocytopenic purpura who received platelet transfusions.Yoshii, Yumi; Fujimura, Yoshihiro; Bennett, Charles L.; Isonishi, Ayami; Kurumatani, Norio; Matsumoto, Masanori
24-Jan-2018Intravitreal injection of aflibercept, an anti-VEGF antagonist, down-regulates plasma von Willebrand factor in patients with age-related macular degeneration.Yamashita, Mariko; Matsumoto, Masanori; Hayakawa, Masaki; Sakai, Kazuya; Fujimura, Yoshihiro; Ogata, Nahoko
Jul-2019Involvement of the ADAMTS13-VWF axis in acute Kawasaki disease and effects of intravenous immunoglobulin.Tsujii, Nobuyuki; Nogami, Keiji; Matsumoto, Masanori; Yoshizawa, Hiroyuki; Takase, Toshio; Tanaka, Ichiro; Sakai, Toshiyuki; Fukuda, Kazuyoshi; Hayakawa, Masaki; Sakai, Kazuya; Isonishi, Ayami; Matsuura, Kayoko; Fujimura, Yoshihiro; Shima, Midori
22-Jul-2011Natural history of Upshaw-Schulman syndrome based on ADAMTS13 gene analysis in JapanFujimura, Yoshihiro; Matsumoto, Masanori; Isonishi, Ayami; Yagi, Hideo; Kokame, Koichi; Soejima, Kenji; Murata, Mitsuru; Miyata, Toshiyuki
Oct-2015Poor responder to plasma exchange therapy in acquired thrombotic thrombocytopenic purpura is associated with ADAMTS13 inhibitor boosting: visualization of an ADAMTS13 inhibitor complex and its proteolytic clearance from plasma.Isonishi, Ayami; Bennett, Charles L.; Plaimauer, Barbara; Scheiflinger, Friedrich; Matsumoto, Masanori; Fujimura, Yoshihiro
1-Oct-2016Rapid Restoration of Thrombus Formation and High-Molecular-Weight von Willebrand Factor Multimers in Patients with Severe Aortic Stenosis After Valve Replacement.Yamashita, Keigo; Yagi, Hideo; Hayakawa, Masaki; Abe, Takehisa; Hayata, Yoshihiro; Yamaguchi, Naoko; Sugimoto, Mitsuhiko; Fujimura, Yoshihiro; Matsumoto, Masanori; Taniguchi, Shigeki
May-2013Ratio of von Willebrand factor propeptide to ADAMTS13 is associated with severity of sepsis.Fukushima, Hidetada; Nishio, Kenji; Asai, Hideki; Watanabe, Tomoo; Seki, Tadahiko; Matsui, Hideto; Sugimoto, Mitsuhiko; Matsumoto, Masanori; Fujimura, Yoshihiro; Okuchi, Kazuo
Sep-2012Reduced larger von Willebrand factor multimers at dawn in OSA plasmas reflect severity of apnoeic episodes.Koyama, Noriko; Matsumoto, Masanori; Tamaki, Shinji; Yoshikawa, Masanori; Fujimura, Yoshihiro; Kimura, Hiroshi
31-Dec-1989Ristocetin血小板凝集を抑制する抗von Willebrand因子モノクローナル抗体の多様性新家, 興; 西尾, 健治; 中井, 寛明; 嶋, 緑倫; 高瀬, 俊夫; 金田, 美喜夫; 吉岡, 章; 福井, 弘; 藤村, 吉博
18-Nov-2015von Willebrand Factor-Rich Platelet Thrombi in the Liver Cause Sinusoidal Obstruction Syndrome following Oxaliplatin-Based Chemotherapy.Nishigori, Naoto; Matsumoto, Masanori; Koyama, Fumikazu; Hayakawa, Masaki; Hatakeyama, Kinta; Hatakeyama, Kinta; Ko, Saiho; Fujimura, Yoshihiro; Nakajima, Yoshiyuki
31-Dec-1989von Willebrand因子(vWF)フラグメント(97 kDa,52/48 kDa,及びFⅢ-T2) と抗vWFモノクローナル抗体NMC-4の免疫反応性新家, 興; 武田, 以知郎; 中井, 寛明; 西尾, 健治; 宮田, 茂樹; 嶋, 緑倫; 吉岡, 章; 福井, 弘; 藤村, 吉博
30-Apr-1989加熱第Ⅷ因子濃縮製剤,Haemate Pの止血管理下に抜歯を行ったType ⅡB von Willebrand病の1例田中, 一郎; 新家, 興; 宮田, 茂樹; 西尾, 健治; 吉岡, 章; 福井, 弘; 藤村, 吉博; 山本, 成美; 杉村, 正仁
10-Oct-1995腎移植患者17例における血中サイトメガロウイルスのPCRによる検出とその臨床的意義松本, 雅則; 藤村, 吉博; 辻内, 智美; 島, 正幸; 下山, 丈人; 成田, 亘啓; 小林, 恵子; 吉田, 佳嗣; 谷口, 繁樹; 北村, 惣一郎; 米田, 龍生; 平尾, 佳彦; 吉田, 克法; 岡島, 英五郎
10-Feb-2009動脈血栓症の制圧 : VWF-GPIb軸依存性血小板血栓形成を調節するADAMTS13の基礎・臨床病態解析藤村, 吉博; 松本, 雅則; 植村, 正人; 杉本, 充彦; 小亀, 浩市; 宮田, 敏行
30-Apr-1992特発性血小板減少性紫斑病(Idiopathic Thrombocytopenic Purpura : ITP)におけるPAIgG値の検討河本, 順雄; 内田, 麻里; 西田, 幸世; 石本, 盛治; 吉田, 英里; 武田, 以知郎; 嶋, 裕子; 水本, 保子; 藤村, 吉博
Showing results 1 to 20 of 22
 next >

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2010  Duraspace - Feedback